What is the effectiveness of the use of polyunsaturated fatty acid omega-3 in the treatment of depression?

Expert Review of Neurotherapeutics

Volumn 10, Issue 7, 2010, Pages 1117-1129

  Rocha Araujo, Daniele Marano ^a   Vilarim, Marina MacHado ^a   Nardi, Antonio E ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

depression; depressive symptoms; DHA; diet; EPA; fish oil; mood; polyunsaturated fatty acid omega 3

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO;

BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL TRIAL; DEPRESSION; DEPRESSION, ANXIETY AND STRESS SCALE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG EFFICACY; GERIATRIC DEPRESSION SCALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRESENT STATE EXAMINATION; RATING SCALE; REVIEW; SCHEDULES FOR CLINICAL ASSESSMENT IN NEUROPSYCHIATRY; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SYSTEMATIC REVIEW; CLINICAL TRIAL (TOPIC);

CLINICAL TRIALS AS TOPIC; DEPRESSION; FATTY ACIDS, OMEGA-3; HUMANS;

EID: 77954191126     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.77     Document Type: Review

References (45)

1. Martin CA, Almeida VV, Ruiz MR et al. [Omega-3 and omega-6 polyunsaturated fatty acids: importance and occurrence in foods]. Revista Nutrição. 19, 761-770 (2006).
2. Tassoni P, Kaur G, Weisinger RS, Sinclair AJ. The role of eicosanoids in the brain. Asia Pad. J. Clin. Nutr. 17, 220-228 (2008).
3. Sinclair AJ, Begg D, Mathai M, Weisinger RS. Omega 3 fatty acids and the brain review of studies in depression. Asia Pad. J. Clin. Nutr. 16, 391-397 (2007).
4. Colin A, Reggers J, Castronovo V, Ansseau M. Lipids, depression and suicide. Encephale 29(1), 49-58 (2003).
5. Zevenbergen H, de Bree A, Zeelenberg M et al. Foods with a high fat quality are essential for healthy diets. Ann. Nutr. Metab. 54, 15-24 (2009).
6. Institute of Medicine (IOM). DRI's-Dietary Reference Intakes for energy, carbohydrate, fber, fat, fatty acids, cholesterol, protein, and amino acids. National Academy Press, Washington, DC, USA (2005).
7. Kris-Etherton PM, Innis S. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J. Am. Diet. Assoc. 107, 1599-1611 (2007).
8. Simopoulous AP. Omega 3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 54, 438-463 (1991).
9. Maes M, Smith R, Christophe A et al Fatty acid composition in major depression: decreased CO 3 fractions in cholesteryl esters and increased C20:4 co6/C20:5 co3 ratio in cholesteryl esters and phospholipids. J. Affec. Disord. 38, 35-46 (1996).
10. Stoll AL, Locke CA, Marangell LB, Severus WE. Omega-3 fatty acids and bipolar disorder: a review. Prostaglandins Leukot. Essent. Fatty Acids 60, 329-337 (1999).
11. Appleton KM, Gunnell D, Peters TJ et al. No clear evidence of an association between plasma concentrations of n-3 long-chain polyunsaturated fatty acids and depressed mood in a non-clinical population. Prostaglandins Leukot. Essent. Fatty Acids 78, 337-1333 (2008).
12. Lin LIK. Concordance correlation coeffcient to evaluete reproducibility. Biometrics 45(1), 255-268 (1989).
13. Giavoni A, Melo GF, Parente I, Dantas G. [Elaboration and validation of the Depression Scale for the Elderly]. Cad. Saude Publica 24, 975-982 (2008).
14. Regier DA, Narrow WE, Rae DS et al. The de facto US mental and addictive disorders service system: epidemiologic Catchment Area prospective 1 year prevalence rates of disorders and services. Arch. Gen. Psychiatry 50, 85-94 (1993).
15. Ustun TB, Sartorius N. Mental Illness in Primary Care: an International Study. John Wiley & Sons Inc, NY, USA (1995).
16. Conklin SM, Manuck SB, Yao JK et al. High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom. Med. 69, 932-934 (2007).
17. Sontrop J, Avison WR, Evers SE et al. Depressive symptoms during pregnancy in relation to fsh consumption and intake of n-3 polyunsaturated fatty acids. Paediatr. Perinat. Epidemiol. 22, 389-399 (2008).
18. Moreira R, Papelbaum M, Appolinario JC et al. [Diabetes mellitus and depression: a systematic review]. Arq. Bras. Endocrinol. Metabol. 47, 19-29 (2003).
19. Conklin SM, Harris JI, Manuck SB et al. Serum w-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. Psychiatry Res. 152, 1-10 (2007).
20. Féart C, Peuchant E, Letenneur L et al. Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of three-city study. Am. J. Clin. Nutr. 87, 1156-1162 (2008).
21. Jacka FN, Pasco JA, Henry MJ et al. Dietary omega-3 fatty acids and depression in a community sample. Nutr. Neurosci. 7, 101-106 (2004).
22. Silvers KM, Woolley CC, Hamilton FC et al. Randomised double-blind placebo-controlled trial of fsh oil in the treatment of depression. Prostaglandins Leukot. Essent. Fatty Acids 72, 211-218 (2005).
23. Su K P. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controled trial. Eur. Neuropsychopharmacol. 13, 267-271 (2003).
24. Mamalakis G, Kiriakakis M, Tsibinos G, Kafatos A. Depression and adipose polyunsaturated fatty acids in the survivors of the seven countries study population of Crete. Prostaglandins Leukot. Essent. Fatty Acids 70, 495-501 (2004).
25. Tiemeier H, Tuijl HR, Hofman A et al. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am. Soc. Clin. Nutr. 78, 40-46 (2003).
26. Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am. J. Psychiatry. 160(5), 996-998 (2003).
27. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56-62 (1960).
28. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J. Affec. Disord. 48, 149-155 (1998). (Pubitemid 28244216)
29. Mischoulon D, Best-Popescu C, Laposata M et al. A double-blind dose-fnding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur. Neuropsychopharmacol. 18, 639-645 (2008).
30. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch. Gen. Psychiatry 59, 913-919 (2002).
31. Grenyer BFS, Crowe T, Meyer B et al. Fish oil supplementation in the treatment of major depression: a randomized double-blind placebo-controlled trial. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 1393-1396 (2007).
32. Rogers P T, Appleton KM, Kessler D et al. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomized controlled trial. Br. J. Nutr. 99(2), 421-431 (2008).
33. Villegas AS, Henriquez P, Figueiras A et al. Long chain omega-3 fatty acids intake, fsh consumption and mental disorders in the SUN cohort study. Eur. J. Nutr. 46, 337-346 (2007).
34. Astorg P, Couthouis A, Bertrais S et al. Association of fsh and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive episodes in middle-aged French men and women. Prostaglandins Leukot. Essent. Fatty Acids 78, 171-182 (2008).
35. Sarri KO, Linardakis M, Tzanakis N, Kafatos AG. Adipose DHA inversely associated with depression as measured by the Beck Depression Inventory. Prostaglandins Leukot. Essent. Fatty Acids 78, 117-122 (2008).
36. Wiehl DG, Reed R. Development of new or improved dietary methods for epidemiological investigations. Am. J.Public Health Nations Health 50, 824-828 (1960).
37. de Salvo VL, Gimeno SG. [Reproducibility and validity of a food frequency questionnaire]. Rev. Saúde Pública 36, 505-512 (2002).
38. Costa AGV, Priore SE, Sabarense CM, Franceschini SCC. [Food frequency questionnaire and 24-hour recall: methodological aspects in the assessment of lipid intake]. Rev. Nutr. 19, 631-641 (2006).
39. Araújo DMR, Pereira NL, Kac G. [Anxiety during pregnancy, prematurity, and low birth weight: a systematic literature review]. Cad. Saude Publica 23, 747-756 (2007).
40. Lin PY, Su K P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant effcacy of omega-3 fatty acids. J. Clin. Psychiatry 68(7), 1056-1061 (2007).
41. Appleton KM, Hayward RC, Gunnell D et al. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am. J. Clin. Nutr. 84(6), 1308-1316 (2007).
42. Horrocks L. A Health benefts of docosahexanoic acid (DHA). Pharmacol. Res. 40, 211-225 (1999).
43. Hibbeln JR. Fish oil consumption and major depression. Lancet 351, 1213 (1998).
44. Dichi I. Comparison of omega-3 fatty acids fatty acids and sulfasalazine in ulcerative colitis. Nutrition 16, 87-90 (2000).
45. Heller A. Lipid mediators in infammatory disorders. Drugs 55, 488-496 (1998).